ABIVAX (ABVX) net assets (shareholders' equity)

Net assets · fiscal 2025
€455.21M

ABIVAX (ABVX) had net assets of €455.21M at the end of fiscal 2025 (December 31, 2025). That is 1021.6% higher than the €40.58M of fiscal 2024. Figures as of 19 Nov 2026, 11:31 UTC, from Yahoo Finance.

Key facts

Net assets, fiscal 2025
€455.21M
Change on fiscal 2024
+1021.6%
Highest on record
€455.21Mfiscal 2025
Lowest on record
€7.19Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

ABIVAX net assets (shareholders' equity), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was €455.21M in fiscal 2025 and the lowest €7.19M in fiscal 2022.

History · 4 fiscal years

Net assets by fiscal year

ABIVAX net assets (shareholders' equity), year by year

ABIVAX (ABVX) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025€455.21M 1,021.6% up
2024€40.58M 79.3% down
2023€196.01M 2,626.5% up
2022€7.19M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of ABIVAX and comparable companies
CompanyNet assetsFiscal year
Alkermes ALKS$1.82B2025
PACS Group PACS$946.77M2025
Kiniksa Pharmaceuticals International KNSA$567.61M2025
ImmunityBio IBRX-$500.47M2025
Cytokinetics CYTK-$659.63M2025
ABIVAX ABVX€455.21M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ABVX

ABIVAX, figure by figure

ABIVAX (ABVX) overview: price, valuation and scorecardAll health care companies by market value

ABIVAX net assets (shareholders' equity): questions and answers

What are ABIVAX's net assets?

ABIVAX (ABVX) had net assets of €455.21M at the end of fiscal 2025 (December 31, 2025). That is 1021.6% higher than the €40.58M of fiscal 2024.

What are the highest and lowest net assets figures on record for ABIVAX?

Across the 4 fiscal years on record (2022–2025), the highest was €455.21M in fiscal 2025 and the lowest €7.19M in fiscal 2022.

How is ABIVAX's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For ABIVAX it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ABIVAX (ABVX) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/ABVX/net-assets

Underlying data: Yahoo Finance.